Marks; Andrew R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Marks; Andrew R..The latest application filed is for "administering inhibitors of tgfbeta signaling in combination with benzothiazepine derivatives to improve muscle function in cancer patients".

Company Profile

0.3.17

Marks; Andrew R. - Larchmont NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Administering Inhibitors Of Tgfbeta Signaling In Combination With Benzothiazepine Derivatives To Improve Muscle Function In Cancer Patients App 20140128349 - Marks; Andrew R. ; et al.	2014-05-08
Inhibition Of Tgfbeta Signaling To Improve Muscle Function In Cancer App 20140127228 - MARKS; Andrew R. ; et al.	2014-05-08
C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis Grant 7,662,178 - Marx , et al. February 16, 2	2010-02-16
Methods And Compositions For Treating Neointimal Hyperplasia App 20090274739 - Marks; Andrew R. ; et al.	2009-11-05
Methods For Identifying Agents That Target Leaks In Ryanodine Receptors App 20090004756 - Marks; Andrew R.	2009-01-01
C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis App 20080208326 - Marx; Steven O. ; et al.	2008-08-28
C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis Grant 7,364,586 - Marx , et al. April 29, 2	2008-04-29
Type 1 ryanodine receptor-based methods Grant 7,312,044 - Marks December 25, 2	2007-12-25
Agents for preventing and treating disorders involving modulation of the RyR receptors App 20070173482 - Marks; Andrew R. ; et al.	2007-07-26
Novel agents for preventing and treating disorders involving modulation of the RyR receptors App 20070049572 - Marks; Andrew R. ; et al.	2007-03-01
Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure App 20060293266 - Marks; Andrew R.	2006-12-28
Novel agents for preventing and treating disorders involving modulation of the RyR receptors App 20060194767 - Marks; Andrew R. ; et al.	2006-08-31
Novel anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof App 20050215540 - Marks, Andrew R. ; et al.	2005-09-29
Type 1 ryanodine receptor-based methods App 20040224368 - Marks, Andrew R.	2004-11-11
Method for treating and preventing cardiac arrhythmia App 20040048780 - Marks, Andrew R.	2004-03-11
Use of Y-27632 as an agent to prevent restenosis after coronary artery angioplasty/stent implantation App 20040028716 - Marks, Andrew R. ; et al.	2004-02-12
Controlling pathways that regulate muscle contraction in the heart App 20030134331 - Marks, Andrew R. ; et al.	2003-07-17
C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis App 20030130722 - Marx, Steven O. ; et al.	2003-07-10
P27 prevents cellular migration App 20030013638 - Marks, Andrew R. ; et al.	2003-01-16
P27 prevents cellular migration App 20020098998 - Marks, Andrew R. ; et al.	2002-07-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.